| 臺大學術典藏 |
2018-09-10T05:10:36Z |
Dose reduction for the management of indinavir-related toxicity in human immunodeficiency virus type 1-infected patients in Taiwan: Clinical and pharmacokinetic assessment
|
Pan, S.-C. and Hsieh, S.-M. and Hung, C.-C. and Huang, P.-F. and Chen, M.-Y. and Chang, S.-C.; SZU-MIN HSIEH |
| 臺大學術典藏 |
2018-09-10T05:14:27Z |
Dose reduction for the management of indinavir-related toxicity in human immunodeficiency virus type 1-infected patients in Taiwan: Clinical and pharmacokinetic assessment
|
Pan, S.-C. and Hsieh, S.-M. and Hung, C.-C. and Huang, P.-F. and Chen, M.-Y. and Chang, S.-C.; SUNG-CHING PAN |
| 臺大學術典藏 |
2018-09-10T05:14:32Z |
Dose reduction for the management of indinavir-related toxicity in human immunodeficiency virus type 1-infected patients in Taiwan: Clinical and pharmacokinetic assessment
|
Pan, S.-C. and Hsieh, S.-M. and Hung, C.-C. and Huang, P.-F. and Chen, M.-Y. and Chang, S.-C.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2020-09-30T02:30:20Z |
Dose reduction for the management of indinavir-related toxicity in human immunodeficiency virus type 1-infected patients in Taiwan: Clinical and pharmacokinetic assessment
|
Sung-Ching Pan;Hsieh S.-M.;Hung C.-C.;Huang P.-F.;Chen M.-Y.;Chang S.-C.; SUNG-CHING PAN; Hsieh S.-M.; Hung C.-C.; Huang P.-F.; Chen M.-Y.; Chang S.-C. |
| 臺大學術典藏 |
2005 |
Dose reduction for the management of indinavir-related toxicity in human immunodeficiency virus type 1-infected patients in Taiwan: Clinical and pharmacokinetic assessment
|
Chang S.-C.; Pan S.-C.;Hsieh S.-M.;Chien-Ching Hung;Huang P.-F.;Chen M.-Y.;Chang S.-C.; Pan S.-C.; Hsieh S.-M.; CHIEN-CHING HUNG; Huang P.-F.; Chen M.-Y. |
| 臺大學術典藏 |
2005 |
Dose reduction for the management of indinavir-related toxicity in human immunodeficiency virus type 1-infected patients in Taiwan: Clinical and pharmacokinetic assessment
|
Chang S.-C.; Huang P.-F.; Chen M.-Y.; SZU-MIN HSIEH; Hung C.-C.; Pan S.-C.; Pan S.-C.;Szu-Min Hsieh;Hung C.-C.;Huang P.-F.;Chen M.-Y.;Chang S.-C. |
| 臺大學術典藏 |
2020-12-30T02:44:25Z |
Dose reduction for the management of indinavir-related toxicity in human immunodeficiency virus type 1-infected patients in Taiwan: Clinical and pharmacokinetic assessment
|
Pan S.-C.;Hsieh S.-M.;Hung C.-C.;Huang P.-F.;Chen M.-Y.;Shan-Chwen Chang; Pan S.-C.; Hsieh S.-M.; Hung C.-C.; Huang P.-F.; Chen M.-Y.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2021-12-01T02:30:18Z |
Dose reduction for the management of indinavir-related toxicity in human immunodeficiency virus type 1-infected patients in Taiwan: Clinical and pharmacokinetic assessment
|
Pan S.-C.; Hsieh S.-M.; CHIEN-CHING HUNG; Huang P.-F.; Chen M.-Y.; Chang S.-C. |
| 高雄醫學大學 |
2009 |
Dose reduction of parotid gland in treatment of Nasopharyngeal cancer with Helical Tomotherapy
|
連熙隆;方本詞;黃志仁;黃旼儀;白立柱;李惠娥 |
| 淡江大學 |
2008-07 |
Dose Self-efficacy Affect Career Commitment? Evidence from the Foodservice Industry
|
牛涵錚; Chen, Li-chan; Wang, Yau-de; Yang, chyan |
| 亞洲大學 |
2012 |
Dose the Purchasing of Directors’ Liability Insurance Enhance or Mitigate a Firm’s Overinvestment
|
Chen, Chia-Wei;Lin, Pin-Shiuan |
| 國立臺灣大學 |
1993 |
Dose Titration Study of Isradipine in Chinese Patients with Mild to Moderate Essential Hypertension
|
廖朝崧; 陳明豐; Chen, C. C.; Chen, W. J.; Wu, C. C.; 李源德; 廖朝崧; 陳明豐; Chen, C. C.; Chen, W. J.; Wu, C. C.; Lee, Yuang-Teh |
| 臺大學術典藏 |
2020-02-27T07:43:51Z |
Dose titration study of isradipine in Chinese patients with mild to moderate essential hypertension
|
Chen C.-C.; WEN-JONE CHEN; Wu C.-C.; Liau C.-S.; Lee Y.-T.; Lee Y.-T.;Liau C.-S.;Wu C.-C.;WEN-JONE CHEN;Chen C.-C.;Chen M.-F.; Chen M.-F. |
| 臺大學術典藏 |
2020-03-04T09:03:38Z |
Dose titration study of isradipine in Chinese patients with mild to moderate essential hypertension
|
Chen M.-F.; Chen C.-C.; Chen W.-J.; CHAU-CHUNG WU; Liau C.-S.; Lee Y.-T. |
| 臺大學術典藏 |
1993 |
Dose titration study of isradipine in Chinese patients with mild to moderate essential hypertension
|
Chen M.-F.; Chen C.-C.; WEN-JONE CHEN; Wu C.-C.; Liau C.-S.; Lee Y.-T. |
| 國立臺灣大學 |
1993 |
Dose Titration Study of Isradipine in Chinese Patients with Mild to Morderate Essential Hypertension
|
Chen, M. F.; Chen, C. C.; 陳維昭; 吳造中; Liau, C. S.; Lee, Y. T.; Chen, M. F.; Chen, C. C.; Chen, Wei-Jao; Wu, Chau-Chung; Liau, C. S.; Lee, Y. T. |
| 國立政治大學 |
2010-01-29 |
Dose transformational leadership facilitate SBU innovation? The moderating roles of SBU culture and incentive compensation
|
林月雲; 陳怡靜; Mavis Yi-Ching Chen; Carol Yeh-Yun Lin |
| 中國醫藥大學 |
2008-10-25 |
Dose using calcium phosphate bone cement contribute to the maintainence of alignment in patients with distal radial fracture treated with CREF?
|
林承志(Cheng-Jyh Lin); 許弘昌(Horng-Chaung Hsu); 洪誌鴻(Chi-Horng Horng) |
| 臺大學術典藏 |
2020-03-05T05:51:22Z |
Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients
|
Kuo S.-H.;Huang-Chun Lien;You S.-L.;Lu Y.-S.;Lin C.-H.;Chen T.-Z.;Huang C.-S.; Kuo S.-H.; HUANG-CHUN LIEN; You S.-L.; Lu Y.-S.; Lin C.-H.; Chen T.-Z.; Huang C.-S. |
| 國立臺灣大學 |
2008 |
Dose Variation and Regimen Modification of Adjuvant Chemotherapy in Daily Practice Affect Survival of Stage I-Ii and Operable Stage Iii Taiwanese Breast Cancer Patients
|
郭頌鑫; 連晃駿; 游山林; 盧彥伸; 林璟宏; 黃俊升; KUO, SUNG-HSIN; LIEN, HUANG-CHUN; YOU, SAN-LIN; LU, YEN-SHEN; LIN, CHING-HUNG; HUANG, CHIUN-SHENG |
| 臺大學術典藏 |
2008 |
Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients
|
Kuo S.-H.; Lien H.-C.; You S.-L.; Lu Y.-S.; Lin C.-H.; Chen T.-Z.; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2020-05-25T06:52:06Z |
Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients
|
Huang C.-S.;Chen T.-Z;Lin C.-H;Yen-Shen Lu;You S.-L;Lien H.-C;Kuo S.-H; Kuo S.-H; Lien H.-C; You S.-L; YEN-SHEN LU; Lin C.-H; Chen T.-Z; Huang C.-S. |
| 臺大學術典藏 |
2021-02-23T08:26:39Z |
Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients
|
Sung-Hsin Kuo;Lien H.-C.;You S.-L.;Lu Y.-S.;Lin C.-H.;Chen T.-Z.;Huang C.-S.; SUNG-HSIN KUO; Lien H.-C.; You S.-L.; Lu Y.-S.; Lin C.-H.; Chen T.-Z.; Huang C.-S. |
| 臺大學術典藏 |
2021-07-28T06:46:58Z |
Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients
|
Kuo S.-H.; Lien H.-C.; You S.-L.; Lu Y.-S.; CHING-HUNG LIN; Chen T.-Z.; Huang C.-S. |
| 國立臺灣大學 |
2008-06 |
Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients.
|
Kuo, SH; Lien, HC; You, SL; Lu, YS; Lin, CH; Chen, TZ; Huang, CS. |
